{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:00:35Z","timestamp":1777327235123,"version":"3.51.4"},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Women's Dermatology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ijwd.2019.09.003","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T05:57:27Z","timestamp":1571205447000},"page":"389-390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The novel use of mu-opioid receptor antagonism for the treatment of refractory pruritus in Kyrle\u2019s disease"],"prefix":"10.1097","volume":"5","author":[{"given":"Mahtab","family":"Forouzandeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea D.","family":"Maderal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijwd.2019.09.003_b0005","first-page":"222","article-title":"Kyrle\u2019s disease: a cutaneous marker of renal disorder","volume":"62","author":"Joseph","year":"1996","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"12","key":"10.1016\/j.ijwd.2019.09.003_b0010","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1093\/ndt\/gfl461","article-title":"Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"21","author":"Pisoni","year":"2006","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.ijwd.2019.09.003_b0015","doi-asserted-by":"crossref","DOI":"10.1177\/2054358116675345","article-title":"Targeting the opioid pathway for uremic pruritus: a systematic review and meta-analysis","volume":"3","author":"Jaiswal","year":"2016","journal-title":"Can J Kidney Health Dis"},{"issue":"3","key":"10.1016\/j.ijwd.2019.09.003_b0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaad.2005.12.010","article-title":"Butorphanol for treatment of intractable pruritus","volume":"54","author":"Dawn","year":"2006","journal-title":"J Am Acad Dermatol"}],"container-title":["International Journal of Women's Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647519301017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647519301017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T14:27:24Z","timestamp":1641565644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352647519301017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":4,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S2352647519301017"],"URL":"https:\/\/doi.org\/10.1016\/j.ijwd.2019.09.003","relation":{},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The novel use of mu-opioid receptor antagonism for the treatment of refractory pruritus in Kyrle\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Women's Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijwd.2019.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc. on behalf of Women's Dermatologic Society.","name":"copyright","label":"Copyright"}]}}